BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Fergus Couch talks to ecancer at EAPM 2017 in Belfast.
He discusses personalised medicine for inherited breast cancer.
He explains how the risk factors are combined to form an accurate risk rating.
Again, the need for data sharing is reiterated to help provide better treatments.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Burden and trends of breast cancer worldwide: Opportunities for prevention?
The added value of integrative medicine
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Genomic testing: Awareness and effective communication between healthcare professionals and patients
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer